top of page

CRO M&A deals reach new record, but what does this mean for clinical trial sponsors?

According to Clinical Trials Arena, "the number of mergers and acquisitions (M&A) among contract research organizations (CROs) saw an uptick in 2021 despite the Covid-19 pandemic. Last year saw 50 completed M&A deals, increasing by 21 completed deals compared to 2020s 29 M&As."

What caused this record number? Service providers were looking to expand their capabilities through M&As rather than building the same offerings internally.



bottom of page